GSK logo

GSK

GSK | NYSE
Chart Builder DCF Calculator
$50.41
-$0.04 (-0.08%)
At close: Nov 16, 2026, 4:00 PM ET
$50.25
-$0.16 (-0.32%)
After-hours: Nov 16, 2026, 7:10 PM ET
-0.08%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
52.1
-1.0 pts
Fundamentals Average
Market Sentiment Neutral
Moat Wide
Sector Rank #238/1021 (Top 23%)

Why Price Moved

7 days ago
+2.4%

Shares are trading higher after GSK accelerated la...

Key Statistics

Market Data

Market Cap $101.33B
1D Range
50.38 51.43
52W Range
46.11 61.18

Valuation (TTM)

PE 17.41
PB 4.05
EV/EBITDA 11.15

Valuation (NTM)

Forward PE 10.54
Forward PEG 2.99
Price Target $57.95
Loading financial charts...

Profile

GSK plc, a global pharmaceutical entity founded in 1715 and headquartered in Brentford, United Kingdom, dedicates its efforts to the research, development, and manufacturing of a wide array of medical...

Sector Healthcare
Employees 66,841
IPO Date Mar 28, 1980
Website www.gsk.com
Fiscal Year January - December

Latest News

GSK: 3 Key Takeaways for Long-Term Investors

1 hour ago · fool.com

GSK: 3 Key Takeaways for Long-Term Investors
GSK Accelerates Late-Stage Studies as It Targets COPD and Long-Acting Respiratory Treatments

7 days ago · marketbeat.com

GSK Accelerates Late-Stage Studies as It Targets COPD and Long-Acting Respiratory Treatments
GSK, Moderna settle patent dispute over Moderna COVID, RSV shots

11 days ago · reuters.com

GSK, Moderna settle patent dispute over Moderna COVID, RSV shots
HP taps Emma Walmsley, ex-GSK chief and Microsoft board member, as CEO

13 days ago · nypost.com

HP taps Emma Walmsley, ex-GSK chief and Microsoft board member, as CEO
GSK: The Gas Pedal Is Still Down, But Bumps Ahead

18 days ago · seekingalpha.com

GSK: The Gas Pedal Is Still Down, But Bumps Ahead
GSK vs. Moderna: Which Large-Cap Biotech Stock Offers More Growth?

19 days ago · zacks.com

GSK vs. Moderna: Which Large-Cap Biotech Stock Offers More Growth?
GSK plc (GSK) Q3 2026 Earnings Call Transcript

19 days ago · seekingalpha.com

GSK plc (GSK) Q3 2026 Earnings Call Transcript
What GSK (GSK) Said on Its Q3 Earnings Call

19 days ago · marketbeat.com

What GSK (GSK) Said on Its Q3 Earnings Call
GSK Q3 Earnings Top Mark, Stock Down on Soft Vaccines Sales

20 days ago · zacks.com

GSK Q3 Earnings Top Mark, Stock Down on Soft Vaccines Sales
GSK's Specialty Drugs Grow by Double Digits While Vaccines Slip in a Q3 Beat

20 days ago · benzinga.com

GSK's Specialty Drugs Grow by Double Digits While Vaccines Slip in a Q3 Beat

Earnings

Latest Earnings
Oct 28, 2026
EPS
$1.47
Beat +5.00%
REV
$11.82B
Beat +0.37%
Next Earnings
Feb 3, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
2
Consensus
Hold
Price Target
$57.95
Upside
+14.96%
Buy (0)
Hold (1)
Sell (1)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.